Takeda Takes Stake, Inks Deal With Newly Launched Izana Bioscience Post author:Sam Post published:December 13, 2017 Post category:BioPharma As part of the licence agreement, Takeda has taken a strategic equity stake in Izana. Source: BioSpace You Might Also Like FDA Warns Physicians on Endoleaks With Stent Grafts September 28, 2017 China Pharma Holdings Reports First Quarter 2017 Financial Results May 11, 2017 Rexahn Pharmaceuticals, Inc. Announces Retirement Of Its Founder, From The Board Of Directors August 31, 2017
Rexahn Pharmaceuticals, Inc. Announces Retirement Of Its Founder, From The Board Of Directors August 31, 2017
